Treatment with Edoxaban Attenuates Acute Stroke Severity in Mice by Reducing Blood–Brain Barrier Damage and Inflammation

Patients with atrial fibrillation and previous ischemic stroke (IS) are at increased risk of cerebrovascular events despite anticoagulation. In these patients, treatment with non-vitamin K oral anticoagulants (NOAC) such as edoxaban reduced the probability and severity of further IS without increasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bieber, Michael, Foerster, Kathrin I., Haefeli, Walter E., Pham, Mirko, Schuhmann, Michael K., Kraft, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464921/
https://www.ncbi.nlm.nih.gov/pubmed/34576055
http://dx.doi.org/10.3390/ijms22189893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464921/
https://www.ncbi.nlm.nih.gov/pubmed/34576055
http://dx.doi.org/10.3390/ijms22189893

Ejemplares similares